Objectives: When a labor process is complicated by non-reassuring fetal status (NRFS), obstetricians focus on delivery to optimize neonatal status. We explored maternal morbidity in the setting of NRFS. Our hypothesis is that delivery of a live newborn with NRFS is associated with significant maternal morbidity. Design, Participants, Setting, and Methods: A large retrospective cohort study of 27,886 women who delivered between January 2013 and December 2016 in a single health system was studied. Inclusion criteria included (1) women over the age of 18 at the time of admission; (2) singleton pregnancy; (3) live birth; and (4) gestational age greater than or equal to 37 weeks at the time of admission. NRFS was defined as umbilical cord pH less than or equal to 7.00, fetal bradycardia, late decelerations, and/or umbilical artery base excess ≤−12. Univariate and multivariate logistic regression and propensity score analyses were performed, and propensity score adjusted odds ratios (AORPS) were derived. p values <0.05 were considered statistically significant. Primary outcomes are maternal blood transfusion, maternal readmission, maternal intensive care unit (ICU) admission, and cesarean delivery in relation to umbilical artery pH, fetal bradycardia, and late decelerations. Results: Umbilical artery pH less than or equal to 7 was associated with maternal blood transfusion (AORPS 6.83 [95% CI 2.22–21.0, p < 0.001]), maternal readmission (AORPS 12.6 [95% CI 2.26–69.8, p = 0.0039]), and cesarean delivery (AORPS 5.76 [95% CI 3.63–9.15, p < 0.0001]). Fetal bradycardia was associated with transfusion (AORPS 2.13 [95% CI 1.26–3.59, p < 0.005]) and maternal ICU admission (AORPS 3.22 [95% CI 1.23–8.46, p < 0.017]). Late decelerations were associated with cesarean delivery (AORPS 1.65 [95% CI 1.55–1.76, p < 0.0001]), clinical chorioamnionitis (AORPS 2.88 [95% CI 2.46–3.37, p < 0.0001]), and maternal need for antibiotics (AORPS 1.89 [95% CI 1.66–2.15, p < 0.0001]). Umbilical artery base excess less than or equal to −12 was associated with readmission (AORPS 6.71 [95% CI 2.22–20.3, p = 0.0007]), clinical chorioamnionitis (AORPS 1.89 [95% CI 1.24–2.89, p = 0.0031]), and maternal need for antibiotics (AORPS 1.53 [95% CI 1.03–2.26, p = 0.0344]). Limitations: The retrospective design contributes to potential bias compared to the prospective design. However, by utilizing multivariate logistic regression analysis with a propensity score method, specifically inverse probability of treatment weighting, we attempted to minimize the impact of confounding variables. Additionally, only a portion of the data set had quantitative blood losses recorded, while the remainder had estimated blood losses. Conclusion: NRFS is associated with significant maternal complications, in the form of increased need for blood transfusions, ICU admissions, and increased infection and readmission rates. Strategies for minimizing maternal complications need to be proactively considered in the management of NRFS.

American College of Obstetricians and Gynecologists. Practice bulletin no. 116: management of intrapartum fetal heart rate tracings. Obstet Gynecol. 2010;116(5):1232–40.
Crovetto F, Cesano N, Rossi F, Acerboni S, Marinis SDE, Basso A, et al. Intrapartum prediction of emergency delivery due to non-reassuring fetal status at 40 weeks’ gestation in low-risk pregnancies: contribution of Doppler parameters, maternal history, and intrapartum clinical characteristics. J Matern Fetal Neonatal Med. 2019;34(17):2816–24.
Grace L, Greer RM, Kumar S. Perinatal consequences of a category 1 caesarean section at term. BMJ Open. 2015;5(7):e007248.
Jenniskens K, Janssen PA. Newborn outcomes in british columbia after caesarean section for non-reassuring fetal status. J Obstet Gynaecol Can. 2015;37(3):207–13.
Mendis R, Flatley C, Kumar S. Maternal demographic factors associated with emergency caesarean section for non-reassuring foetal status. J Perinat Med. 2018;46(6):641–7.
Morokuma S, Michikawa T, Kato K, Sanefuji M, Shibata E, Tsuji M, et al. Non-reassuring foetal status and neonatal irritability in the Japan Environment and Children’s Study: a cohort study. Sci Rep. 2018;8(1):15853.
Pires-Menard A, Flatley C, Kumar S. Severe neonatal outcomes associated with emergency cesarean section at term. J Matern Fetal Neonatal Med. 2019;34(4):629–33.
Schmidt S, Koslowski S, Sierra F, Meyer-Wittkopf M, Heller G. Clinical usefulness of pulse oximetry in the fetus with non-reassuring heart rate pattern?J Perinat Med. 2000;28(4):298–305.
Teo EY, Kumar S. Intrapartum intervention rates and perinatal outcomes following induction of labour after 41 + 0 weeks compared to expectant management. J Matern Fetal Neonatal Med. 2017;30(21):2517–20.
Turner E, Warshak CR. Cesarean for non-reassuring fetal status: effect of obesity on decision to delivery interval. J Perinatol. 2019;39(6):814–9.
Wood S, Ross S, Sauve R. Cesarean section and subsequent stillbirth, is confounding by indication responsible for the apparent association? An updated cohort analysis of a large perinatal database. PLoS One. 2015;10(9):e0136272.
East CE, Leader LR, Sheehan P, Henshall NE, Colditz PB, Lau R. Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace. Cochrane Database Syst Rev. 2015(5):CD006174.
Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics. 2011;128(2):344–55.
Maternity and obstetric care in southeast Michigan. Beaumont health; 2020. Available from: https://www.beaumont.org/services/womens-services/maternity.
Collins P, Abdul-Kadir R, Thachil J; Subcommittees on Women’ s Health Issues in Thrombosis and Haemostasis and on Disseminated Intravascular Coagulation. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(1):205–10.
Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin No. 199: use of prophylactic antibiotics in labor and delivery. Obstet Gynecol. 2018;132(3):e103–19.
Lalonde A, International Federation of Gynecology and Obstetrics. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117(2):108–18.
Leduc D, Senikas V, Lalonde AB. No. 235-Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2018;40(12):e841–55.
Main EK, Goffman D, Scavone BM, Low LK, Bingham D, Fontaine PL, et al. National partnership for maternal safety: consensus bundle on obstetric hemorrhage. Obstet Gynecol. 2015;126(1):155–62.
Alhousseini A, Romero R, Benshalom-Tirosh N, Gudicha D, Pacora P, Tirosh D, et al. Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion. J Matern Fetal Neonatal Med. 2022;35(2):242–57.
Kawakita T, Mokhtari N, Huang JC, Landy HJ. Evaluation of risk-assessment tools for severe postpartum hemorrhage in women undergoing cesarean delivery. Obstet Gynecol. 2019;134(6):1308–16.
Nathan HL, Seed PT, Hezelgrave NL, De Greeff A, Lawley E, Anthony J, et al. Shock index thresholds to predict adverse outcomes in maternal hemorrhage and sepsis: a prospective cohort study. Acta Obstet Gynecol Scand. 2019;98(9):1178–86.
Haeri S, Dildy GA3rd. Maternal mortality from hemorrhage. Semin Perinatol. 2012;36(1):48–55.
Wu E, Jolley JA, Hargrove BA, Caughey AB, Chung JH. Implementation of an obstetric hemorrhage risk assessment: validation and evaluation of its impact on pretransfusion testing and hemorrhage outcomes. J Matern Fetal Neonatal Med. 2015;28(1):71–6.
Ituk U, Habib AS. Enhanced recovery after cesarean delivery. F1000Res. 2018;7:F1000 Faculty Rev-513.
Matas ML, Sharma SV, Louis JM, Salemi JL. Severe maternal morbidity at delivery and postpartum readmission in the United States. Paediatr Perinat Epidemiol. 2021;35(6):627–634.
Hire MG, Lange EMS, Vaidyanathan M, Armour KL, Toledo P. Effect of quantification of blood loss on activation of a postpartum hemorrhage protocol and use of resources. J Obstet Gynecol Neonatal Nurs. 2020;49(2):137–43.
You do not currently have access to this content.